Novast Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?
NOVAST LABS has eighty-four approved drugs.
There are three tentative approvals on NOVAST LABS drugs.
Drugs and US Patents for Novast Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novast Labs | FLUOROURACIL | fluorouracil | INJECTABLE;INJECTION | 209271-001 | Dec 11, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Novast Labs | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 206935-001 | May 26, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novast Labs | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 208487-002 | Apr 26, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novast Labs | TRIAZOLAM | triazolam | TABLET;ORAL | 214219-002 | Oct 20, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novast Labs | DOFETILIDE | dofetilide | CAPSULE;ORAL | 212410-001 | Dec 27, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Novast Labs | DOFETILIDE | dofetilide | CAPSULE;ORAL | 212410-002 | Dec 27, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Novast Labs | QUININE SULFATE | quinine sulfate | CAPSULE;ORAL | 204372-001 | Jul 22, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.